Predictors of Subclinical Cardiovascular Disease in Women with Polycystic Ovary Syndrome: Interrelationship of Dyslipidemia and Arterial Blood Pressure

Triglyceride/High-Density Lipoprotein Cholesterol Concentration Ratio Identifies Accentuated Cardio-Metabolic Risk

(2015) John Armato et al.   Endocrine Practice

European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire

(2014) Gerard Conway et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?

(2014) Nadine M.P. Daan et al.   FERTILITY AND STERILITY

Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors

(2013) Yuhua Shi et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors

(2013) E. Carmina et al.   HUMAN REPRODUCTION

Lifecycle of Polycystic Ovary Syndrome (PCOS): From In Utero to Menopause

(2013) Corrine K. Welt et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Relation Among the Plasma Triglyceride/High-Density Lipoprotein Cholesterol Concentration Ratio, Insulin Resistance, and Associated Cardio-Metabolic Risk Factors in Men and Women

(2012) Martin R. Salazar et al.   AMERICAN JOURNAL OF CARDIOLOGY

Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity

(2012) H. Kahal et al.   CLINICAL ENDOCRINOLOGY

Prevalence of metabolic syndrome in women with polycystic ovary syndrome

(2012) Dimitrios Panidis et al.   CLINICAL ENDOCRINOLOGY

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications

(2012) Evanthia Diamanti-Kandarakis et al.   ENDOCRINE REVIEWS

Ovarian Hypertension: Polycystic Ovary Syndrome

(2011) Rhonda Bentley-Lewis et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

(2011) Bart C.J.M. Fauser et al.   FERTILITY AND STERILITY

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society

(2011) H.F. Escobar-Morreale et al.   HUMAN REPRODUCTION UPDATE

Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?

(2010) J. Tomlinson et al.   DIABETIC MEDICINE

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

(2010) Lisa J. Moran et al.   HUMAN REPRODUCTION UPDATE

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

(2010) Robert A. Wild et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The role of low-grade inflammation in the polycystic ovary syndrome

(2010) Andrea Repaci et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Lipid and lipoprotein profile in women with polycystic ovary syndromeThis article is one of a selection of papers published in the special issue Bridging the Gap: Where Progress in Cardiovascular and Neurophysiologic Research Meet.

(2008) Djuro Macut et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation

(2008) Leslee J. Shaw et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM